Arun Balakumaran, new Replay and Syena CMO
May 18, 2023 06:30 AM EDTUpdated 09:33 AM
People
Cell/Gene Tx

Ex­clu­sive: Cell and gene ther­a­py biotech cre­ator Re­play plucks Al­lo­gene CMO Arun Bal­aku­maran to lead clin­i­cal tri­als

Kyle LaHucik

Senior Reporter

Arun Bal­aku­maran re­mem­bers work­ing down the cor­ri­dor at the NIH from fel­low re­searcher Katy Rez­vani back in the aughts. He nev­er pic­tured the duo work­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­vo Nordisk part­ners with Broad In­sti­tute spin­out Pho­tys af­ter the star­tup's lay­offs

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

Ex­clu­sive: In­sitro makes head­way on the hard­er road, dis­cov­er­ing new ALS drug tar­get

Flag­ship gene ther­a­py start­up Ring Ther­a­peu­tics near­ly halves work­force in lat­est job cuts

SiteOne Ther­a­peu­tics, a pain biotech that's part­nered with Ver­tex, nabs $100M

Au­ri­on’s eye cell ther­a­py im­proves vi­sion in small study, plots Phase 3 tri­al

A service from the Financial Times